Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CuriosityStream ( (CURI) ) has issued an update.
On January 28, 2026, CuriosityStream’s board declared a $0.08 quarterly dividend payable March 20 to shareholders of record March 6, underscoring continued free-cash-flow strength and expanding AI-driven data licensing revenue. Management emphasized that scaling diversified income streams—subscriptions, content licensing, advertising, FAST/AVOD distribution, strategic partnerships, and the growing supply of premium video and audio for AI training customers—reinforces the company’s role as a dependable provider of factual content and supports durable returns to investors.
The most recent analyst rating on (CURI) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on CuriosityStream stock, see the CURI Stock Forecast page.
Spark’s Take on CURI Stock
According to Spark, TipRanks’ AI Analyst, CURI is a Neutral.
The score is driven primarily by improving fundamentals (positive and growing free cash flow and low leverage) and a constructive earnings update with strong licensing-led growth and guidance execution. Offsetting this are weak technicals (downtrend despite oversold readings) and ongoing GAAP losses, which also reduce valuation clarity despite the high dividend yield.
To see Spark’s full report on CURI stock, click here.
More about CuriosityStream
CuriosityStream is a global factual entertainment media company with a multi-platform portfolio spanning its flagship subscription streaming service, linear channels, ad-supported outlets, audio network, and original production studio, providing award-winning science, nature, history, technology, society, and lifestyle content to millions of subscribers in over 175 countries.
Average Trading Volume: 792,923
Technical Sentiment Signal: Hold
Current Market Cap: $216.9M
Learn more about CURI stock on TipRanks’ Stock Analysis page.

